MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$3,323,855
Net loss
-$33,846,661
Total other income,
net
$1,418,545
Interest expense
$1,905,310
Loss from operations
-$35,265,206
Research and development
$25,662,855
General and
administrative
$9,602,351
Back
Back
Income Statement
source: myfinsight.com
Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. (ALDX)